Cell & Gene Therapy Summit (CGTS)

Overview of event

As the global leader in outsourced sample storage and management, we connected with CGT developers, biopharma scientists, and manufacturing leaders advancing breakthrough therapies. These innovative therapies demand uncompromising standards for sample preservation, especially for high-value assets like viral vectors, genetically modified cell lines, and stability batches.

At CGTS, we showcased our integrated storage and business continuity solutions—ranging from -80°C to vapour-phase LN₂ (-196°C)—and highlighted how our approach enables CGT teams to mitigate risk, accelerate timelines, and remain compliant with global regulatory expectations. Our experts were on hand to explore how Astoriom serve as a trusted infrastructure partner from preclinical research through to commercial readiness.